Jean-Paul Clozel, CEO Actelion - YouTube
Actelion offers sweetener to stave off attacks - SWI swissinfo.ch
Jean-Paul Clozel | EY - Global
Actelion wins FDA approval for hypertension drug - San Francisco Business Times
Actelion - Wikipedia
Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»
Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News in France
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
Jean-Paul Clozel, co-founder of Actelion Ltd., speaks during a news... News Photo - Getty Images
Der Actelion-Gründer hat alle seine Ziele erreicht – und beginnt von vorn | NZZ
Jean-Paul Clozel: «Idorsia steht nicht zum Verkauf» | Finanz und Wirtschaft
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia (October 2017)
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Profile: Jean-Paul Clozel | Nature Biotechnology
Actelion Could Boost Takeover Price for Johnson & Johnson
Actelion: independent thinking | Financial Times
Actelion CEO and founder Jean-Paul Clozel attends a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Photo Stock - Alamy
Jean-Paul Clozel
We could be the 1st EU-Biopharma entering the Major League"
Swiss biotech group Actelion CEO Jean-Paul Clozel arrives for his company's annual general meeting in Basel, May 5, 2011. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS HEALTH Stock Photo - Alamy
Jean-Paul Clozel
